John Fowler
2017
In 2017, John Fowler earned a total compensation of $799.3K as Chief Executive Officer at Kezar Life Sciences.
Compensation breakdown
| Non-Equity Incentive Plan | $130,000 |
|---|---|
| Option Awards | $298,476 |
| Salary | $360,000 |
| Other | $10,800 |
| Total | $799,276 |
Fowler received $360K in salary, accounting for 45% of the total pay in 2017.
Fowler also received $130K in non-equity incentive plan, $298.5K in option awards and $10.8K in other compensation.
Rankings
In 2017, John Fowler's compensation ranked 10,035th out of 14,666 executives tracked by ExecPay. In other words, Fowler earned more than 31.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,035 out of 14,666 | 32nd |
Division Manufacturing | 3,878 out of 5,772 | 33rd |
Major group Chemicals And Allied Products | 1,356 out of 2,075 | 35th |
Industry group Drugs | 1,100 out of 1,731 | 37th |
Industry Pharmaceutical Preparations | 861 out of 1,333 | 35th |
Source: SEC filing on April 30, 2019.
Fowler's colleagues
We found one more compensation record of an executive who worked with John Fowler at Kezar Life Sciences in 2017.
2017
Christopher Kirk
Kezar Life Sciences